Kv1.3 blocking alkoxypsoralens - A new class of immunosuppressants for the potential treatment of multiple sclerosis

被引：0
|
作者：
Wulff, H
Vennekamp, J
Beeton, C
Grissmer, S
Chandy, KG
机构：
[1] Univ Calif Irvine, Irvine, CA 92697 USA
[2] Univ Ulm, D-89069 Ulm, Germany
[3] Univ Kiel, Inst Pharmaceut, D-24098 Kiel, Germany
来源：
FASEB JOURNAL | 2003年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1051 / A1051
页数：1
相关论文
共 50 条
  • [1] Kv1.3 blocking alkoxypsoralens -: A new class of immunomodulators for the treatment of T cell mediated autoimmune diseases?
    Beeton, C
    Vennekamp, J
    Wulff, H
    Chen, CY
    Ananthakrishnan, S
    Calabresi, PA
    Grissmer, S
    Hänsel, W
    Chandy, KG
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 538A - 538A
  • [2] The Kv1.3 channel: a potential biomarker for multiple sclerosis
    Markakis, I.
    Beeton, C.
    Rombos, A.
    Hatzimanolis, A.
    Tsata, V.
    Sfikakis, P.
    Davaki, P.
    Newton, B.
    Pennington, M.
    Chandy, K. G.
    Poulopoulou, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 215 - 215
  • [3] Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels
    Koo, GC
    Blake, JT
    Shah, K
    Staruch, MJ
    Dumont, F
    Wunderler, D
    Sanchez, M
    McManus, OB
    Sirotina-Meisher, A
    Fischer, P
    Boltz, RC
    Goetz, MA
    Baker, R
    Bao, JM
    Kayser, F
    Rupprecht, KM
    Parsons, WH
    Tong, XC
    Ita, IE
    Pivnichny, J
    Vincent, S
    Cunningham, P
    Hora, D
    Feeney, W
    Kaczorowski, G
    Springer, MS
    CELLULAR IMMUNOLOGY, 1999, 197 (02) : 99 - 107
  • [4] Blocking Potassium Channels (Kv1.3): A New Treatment Option for Alopecia Areata?
    Gilhar, Amos
    Keren, Aviad
    Shemer, Avner
    Ullmann, Yehuda
    Paus, Ralf
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (08) : 2088 - 2091
  • [5] A new class of inhibitors of Kv1.3 with immunosuppressant properties
    Slaughter, R
    Schmalhofer, WA
    Green, B
    Matyskiela, M
    Staruch, M
    Linde, A
    McManus, O
    Kaczorowski, G
    Garcia, M
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 584A - 585A
  • [6] Kv1.3 potassium channels as a therapeutic target in multiple sclerosis
    Rangaraju, Srikant
    Chi, Victor
    Pennington, Michael W.
    Chandy, K. George
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (08) : 909 - 924
  • [7] Design and synthesis of new structural class of Kv1.3 inhibitors
    Gubic, S.
    Toplak, Z.
    Hendrickx, L.
    Dobricic, V.
    Tytgat, J.
    Tomasic, T.
    Masic, L. Peterlin
    FEBS OPEN BIO, 2021, 11 : 425 - 425
  • [8] Convergent and enantioselective total synthesis of (-)-nalanthalide, a potential Kv1.3 blocking immunosuppressant
    Abe, T
    Iwasaki, K
    Inoue, M
    Suzuki, T
    Watanabe, K
    Katoh, T
    TETRAHEDRON LETTERS, 2006, 47 (19) : 3251 - 3255
  • [9] MEDI 569-Small molecule blockers of the Kv1.3 ion channel as potential immunosuppressants
    Harvey, Andrew J.
    Baell, Jonathan B.
    Cianci, Julia
    Homerick, Daniel
    Mould, Jorgen
    Toovey, Nathan L.
    Wulff, Heike
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [10] Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma
    Kadow, Stephanie
    Schumacher, Fabian
    Kramer, Melanie
    Hessler, Gabriele
    Scholtysik, Rene
    Oubari, Sara
    Johansson, Patricia
    Huttmann, Andreas
    Reinhardt, Hans Christian
    Kleuser, Burkhard
    Zoratti, Mario
    Mattarei, Andrea
    Szabo, Ildiko
    Gulbins, Erich
    Carpinteiro, Alexander
    CANCERS, 2022, 14 (08)
12345